← Leaderboards
Julie Parsonnet
Stanford University
$19,887,835
Attributed
$22,403,387
Total exposure
20
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,403,387 · 20
By mechanism
R01$13,159,873 · 5
T32$3,338,693 · 2
U01$2,318,888 · 1
R21$2,070,544 · 4
K30$1,000,000 · 1
M01$357,189 · 6
Top collaborators
- Yvonne A. Maldonado5 shared
- Shuchi Anand4 shared
- Glenn Matthew Chertow4 shared
- Justin V Remais1 shared
Most similar at Stanford University
Same institution · by research overlap
- Harry Bernard Greenberg$91,083,131
- Douglas J Passaro$365,527
- Kari C. Nadeau$30,132,783
- Hilary Kessler Seligman$1,930,513
- Lauren Tompkins$1,476,072
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionHelicobacterClinical ResearchEpidemiologyAffectDiarrheaHouseholdCommunicable DiseasesHuman SubjectGastroenteritisIncidenceSamplingChronicResponseFecesCytokinePrevalenceCommunicable Disease TransmissionChildEmesisTransmission ProcessHelicobacter PyloriHelicobacter InfectionsGastrointestinal Infection
Grant awards (70)
Exploratory study of pesticide use and coccidioidomycosis$247,621
R21 · FY2025 · AI · contact PI
Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocation$193,000
R21 · FY2024 · MD
Feasibility of conducting HIV surveillance in community wastewater$193,000
R21 · FY2024 · AI · contact PI
SARS-COV-2 Screening in Dialysis Facilities: Building an Optimal Strategy to Protect High Risk Populations$1,152,360
U01 · FY2023 · AI
Feasibility of conducting HIV surveillance in community wastewater$231,713
R21 · FY2023 · AI · contact PI
Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocation$231,600
R21 · FY2023 · MD
SARS-COV-2 Screening in Dialysis Facilities: Building an Optimal Strategy to Protect High Risk Populations$1,166,528
U01 · FY2022 · AI
Longitudinal investigations of the infant virome and its associations with obesity$507,365
R01 · FY2020 · HD · contact PI
Clinical Epidemiology of Infectious Diseases$218,361
T32 · FY2020 · AI · contact PI
Clinical Epidemiology of Infectious Diseases$223,992
T32 · FY2019 · AI · contact PI
Longitudinal investigations of the infant virome and its associations with obesity$552,083
R01 · FY2018 · HD · contact PI
Clinical Epidemiology of Infectious Diseases$212,244
T32 · FY2018 · AI · contact PI
Longitudinal investigations of the infant virome and its associations with obesity$606,708
R01 · FY2017 · HD · contact PI
Clinical Epidemiology of Infectious Diseases$216,443
T32 · FY2017 · AI · contact PI
Household Triclosan and Triclocarban Use and the Developing Infant Microbiome$319,381
R21 · FY2016 · ES · contact PI
Clinical Epidemiology of Infectious Diseases$254,459
T32 · FY2016 · AI · contact PI
Household Triclosan and Triclocarban Use and the Developing Infant Microbiome$319,532
R21 · FY2015 · ES · contact PI
Household Triclosan and Triclocarban Use and the Developing Infant Microbiome$334,697
R21 · FY2014 · ES · contact PI
Childhood infection and prevention of obesity$705,560
R01 · FY2013 · HD · contact PI
Epidemiology of Emerging Infectious Diseases and Bioterrorism$195,255
T32 · FY2013 · AI · contact PI
Childhood infection and prevention of obesity$734,798
R01 · FY2012 · HD · contact PI
Epidemiology of Emerging Infectious Diseases and Bioterrorism$133,910
T32 · FY2012 · AI · contact PI
Childhood infection and prevention of obesity$721,280
R01 · FY2011 · HD · contact PI
Epidemiology of Emerging Infectious Diseases and Bioterrorism$216,152
T32 · FY2011 · AI · contact PI
Childhood infection and prevention of obesity$44,800
R01 · FY2011 · HD · contact PI
Childhood infection and prevention of obesity$727,804
R01 · FY2010 · HD · contact PI
Epidemiology of Helicobacter Pylori Transmission$700,789
R01 · FY2010 · AI · contact PI
Epidemiology of Helicobacter Pylori Transmission$175,952
R01 · FY2010 · AI · contact PI
Epidemiology of Emerging Infectious Diseases and Bioterrorism$129,172
T32 · FY2010 · AI · contact PI
Childhood infection and prevention of obesity$744,972
R01 · FY2009 · HD · contact PI
Epidemiology of Helicobacter Pylori Transmission$698,295
R01 · FY2009 · AI · contact PI
Epidemiology of Emerging Infectious Diseases and Bioterrorism$128,084
T32 · FY2009 · AI · contact PI
Epidemiology of Helicobacter Pylori Transmission$681,962
R01 · FY2008 · AI · contact PI
CLINICAL TRIAL: CLINICAL EXPERIMENT OF HELICOBACTER PYLORI TRANSMISSION$11,605
M01 · FY2008 · RR · contact PI
DIABETES ON CYTOKINE RESPONSE TO BACILLE CALMETTE GUERIN VACCINATION$10,353
M01 · FY2008 · RR · contact PI
Epidemiology of Helicobacter Pylori Transmission$679,241
R01 · FY2007 · AI · contact PI
CLINICAL EXPERIMENT OF HELICOBACTER PYLORI TRANSMISSION$124,052
M01 · FY2007 · RR · contact PI
Epidemiology of Helicobacter Pylori Transmission$685,412
R01 · FY2006 · AI · contact PI
CLINICAL EXPERIMENT OF HELICOBACTER PYLORI TRANSMISSION$61,824
M01 · FY2006 · RR · contact PI
CLINICAL EXPERIMENT OF HELICOBACTOR PYLORI TRANSMISSION$263,760
R01 · FY2005 · DK
THE CLINICAL EXPERIMENT OF HELICOBACTER PYLORI TRANSMISSION$1,336
M01 · FY2005 · RR
APPLIED GENOMICS IN INFECTIOUS DISEASES$305,511
T32 · FY2004 · AI
CLINICAL EXPERIMENT OF HELICOBACTOR PYLORI TRANSMISSION$263,760
R01 · FY2004 · DK
CLINICAL RESEARCH TRAINING PROGRAM$200,000
K30 · FY2004 · HL
GIS for Extant Data: Modeling H.Pylori and GI Tumors$117,750
R01 · FY2004 · CA
Microarrays of Intermediate Endpoints of Gastric Cancer$80,000
R03 · FY2004 · CA
Clinical Experiment of Helicobacter Pylori Transmission$12,445
M01 · FY2004 · RR
Clinical Experiment of Helicobacter pylori Transmission$296
M01 · FY2004 · RR
EPIDEMIOLOGY OF HELICOBACTER PYLORI TRANSMISSION$617,571
R01 · FY2003 · AI
APPLIED GENOMICS IN INFECTIOUS DISEASES$309,370
T32 · FY2003 · AI
CLINICAL EXPERIMENT OF HELICOBACTOR PYLORI TRANSMISSION$263,760
R01 · FY2003 · DK
CLINICAL RESEARCH TRAINING PROGRAM$200,000
K30 · FY2003 · HL
GIS for Extant Data: Modeling H.Pylori and GI Tumors$117,750
R01 · FY2003 · CA
Microarrays of Intermediate Endpoints of Gastric Cancer$78,200
R03 · FY2003 · CA
EPIDEMIOLOGY OF HELICOBACTER PYLORI TRANSMISSION$640,882
R01 · FY2002 · AI
APPLIED GENOMICS IN INFECTIOUS DISEASES$288,221
T32 · FY2002 · AI
CLINICAL EXPERIMENT OF HELICOBACTOR PYLORI TRANSMISSION$263,760
R01 · FY2002 · DK
CLINICAL RESEARCH TRAINING PROGRAM$200,000
K30 · FY2002 · HL
GIS for Extant Data: Modeling H.Pylori and GI Tumors$114,900
R01 · FY2002 · CA
EPIDEMIOLOGY OF HELICOBACTER PYLORI TRANSMISSION$633,660
R01 · FY2001 · AI
APPLIED GENOMICS IN INFECTIOUS DISEASES$266,367
T32 · FY2001 · AI
CLINICAL EXPERIMENT OF HELICOBACTOR PYLORI TRANSMISSION$255,381
R01 · FY2001 · DK
CLINICAL RESEARCH TRAINING PROGRAM$200,000
K30 · FY2001 · HL
CLINICAL EXPERIMENT OF HELICOBACTER PYLORI TRANSMISSION$134,676
M01 · FY2001 · RR
CLINICAL EXPERIMENT OF HELICOBACTER PYLORI TRANSMISSION$0
M01 · FY2001 · RR
EPIDEMIOLOGY OF HELICOBACTER PYLORI TRANSMISSION$604,091
R01 · FY2000 · AI
APPLIED GENOMICS IN INFECTIOUS DISEASES$241,152
T32 · FY2000 · AI
CLINICAL RESEARCH TRAINING PROGRAM$200,000
K30 · FY2000 · HL
EPIDEMIOLOGY OF HELICOBACTER PYLORI TRANSMISSION$35,827
R01 · FY2000 · AI
CLINICAL EXPERIMENT OF HELICOBACTER PYLORI TRANSMISSION$602
M01 · FY2000 · RR